BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29990107)

  • 1. Human Pathway-Based Disease Network.
    Yu L; Gao L
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(4):1240-1249. PubMed ID: 29990107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
    Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
    Yu L; Zhao J; Gao L
    Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Novel Drugs and Diseases for Hepatocellular Carcinoma Based on Multi-Source Simulated Annealing Based Random Walk.
    Ibrahim SJA; Thangamani M
    J Med Syst; 2018 Sep; 42(10):188. PubMed ID: 30173379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SemFunSim: a new method for measuring disease similarity by integrating semantic and gene functional association.
    Cheng L; Li J; Ju P; Peng J; Wang Y
    PLoS One; 2014; 9(6):e99415. PubMed ID: 24932637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics Database.
    Davis AP; Wiegers TC; King BL; Wiegers J; Grondin CJ; Sciaky D; Johnson RJ; Mattingly CJ
    PLoS One; 2016; 11(5):e0155530. PubMed ID: 27171405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMPUTING THERAPY FOR PRECISION MEDICINE: COLLABORATIVE FILTERING INTEGRATES AND PREDICTS MULTI-ENTITY INTERACTIONS.
    Regenbogen S; Wilkins AD; Lichtarge O
    Pac Symp Biocomput; 2016; 21():21-32. PubMed ID: 26776170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based inference methods for drug repositioning.
    Chen H; Zhang H; Zhang Z; Cao Y; Tang W
    Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MNBDR: A Module Network Based Method for Drug Repositioning.
    Chen HG; Zhou XH
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network.
    Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
    Biomed Res Int; 2021; 2021():1280237. PubMed ID: 34692825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway-based Bayesian inference of drug-disease interactions.
    Pratanwanich N; Lió P
    Mol Biosyst; 2014 Jun; 10(6):1538-48. PubMed ID: 24695945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network controllability solutions for computational drug repurposing using genetic algorithms.
    Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
    Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning using drug-disease vectors based on an integrated network.
    Lee T; Yoon Y
    BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ksRepo: a generalized platform for computational drug repositioning.
    Brown AS; Kong SW; Kohane IS; Patel CJ
    BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway networks generated from human disease phenome.
    Cirincione AG; Clark KL; Kann MG
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):75. PubMed ID: 30255817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.
    Chen H; Zhang Z
    Biomed Res Int; 2015; 2015():406463. PubMed ID: 25789319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.